603087

Gan & Lee Pharmaceuticals.
603087

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥33.44B
EV
CN¥31.09B
Shares Outstanding
598.96M
Beta
1.61

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
CN¥65.00
P/E 2025E
29.78x
P/Revenue 2025E
7.78x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Gan & Lee Pharmaceuticals.

gainify
603087

Gan & Lee Pharmaceuticals.

603087

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. The company’s products include Basalin, an insulin glargine injectio...

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Du, Kai

Employees

5,245

IPO Date

2020-06-29

Headquarters

No. 8, Nanfeng West 1st Street, Huoxian Town, Tongzhou District, Beijing 101109, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.